Clinical Trial Update: A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India [Phase 3]

View source ↗

Summary

Takeda's dengue vaccine TAK-003 was studied in a Phase 3 trial in healthy children, teenagers and adults in India, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• TAK-003 dengue vaccine (TAK-003)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 3 | Status: COMPLETED